Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis

Cutis

Volumn 85, Issue 1, 2010, Pages 43-50

  Poulin, Yves ^a   Papp, Kim ^b   Bissonnette, Robert ^c   Guenther, Lyn ^d   Tan, Jerry ^e   Lynde, Charles ^f   Kerrouche, Nabil ^g   Villemagne, Hervé ^g  

^a Centre de Recherche Dermatologique du Quebec Metropolitain   (Canada)

^b Clinical Research   (Canada)

^c INNOVADERM RESEARCH   (Canada)

^d Guenther Dermatology Research Centre   (Canada)

^e Windsor Clinical Research Inc   (Canada)

^f Lynderm Clinical Research   (Canada)

^g Galderma R and D   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; COSMETIC; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SKIN DISEASE; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLOBETASOL; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HAIR PREPARATIONS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RECURRENCE; SCALP DERMATOSES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949883164     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Van de Kerkhof PC, Franssen ME. Psoriasis of the scalp. diagnosis and management. Am J Clin Dermatol. 2001;2:159-165.
2. Al-Suwaidan SN, Feldman SR. Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol. 2000;42(5, pt 1):796-802.
3. Dawber R, Van Neste D. Hair and Scalp Disorders: Common Presenting Signs, Differential Diagnosis and Treatment. 1st ed. Philadelphia, PA: JB Lippincott; 1995.
4. Papp K, Berth-Jones J, Kragballe K, et al. Scalp psoriasis: a review of current topical treatment options. J Eur Acad Dermatol Venereol. 2007;21:1151-1160.
5. Bewley A. Dermatology Working Group. Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br J Dermatol. 2008;158: 917-920.
6. Van der Vleuten CJ, van de Kerkhof PC. Management of scalp psoriasis: guidelines for corticosteroid use in combination treatment. Drugs. 2001;61:1593-1598.
7. Lebwohl M. A clinician's paradigm in the treatment of psoriasis. J Am Acad Dermatol. 2005;53(suppl 1): S59-S69.
8. du Vivier A, Stoughton RB. Tachyphylaxis to the action of topically applied corticosteroids. Arch Dermatol. 1975;11:581-583.
9. Aso M. The effects of potent topical corticosteroids on adrenocortical function. J Dermatol. 1983;10: 145-149.
10. Feldman SR, Housman TS. Patients' vehicle preference for corticosteroid treatments of scalp psoriasis. Am J Clin Dermatol. 2003;4:221-224.
11. Katz HI, Hien NT, Prawer SE, et al. Betamethasone dipropionate in optimized vehicle. intermittent pulse dosing for extended maintenance treatment of psoriasis. Arch Dermatol. 1987;123:1308-1311.
12. Lebwohl M, Yoles A, Lombardi K, et al. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. J Am Acad Dermatol. 1998;39:447-450.
13. Jarratt M, Breneman D, Gottlieb AB, et al. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis. J Drugs Dermatol. 2004;3:367-373.
14. Reygagne P, Mrowietz U, Decroix J, et al. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in patients with scalp psoriasis. J Dermatolog Treat. 2005;16:31-36.
15. Andres P, Poncet M, Farzaneh S, et al. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in patients with scalp psoriasis. J Drugs Dermatol. 2006;5:328-332.
16. Griffiths CE, Finlay AY, Fleming CJ, et al. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. J Dermatolog Treat. 2006; 17:90-95.
17. Wulff-Woesten A, Ohlendorf D, Henz BM, et al. Dithranol in an emulsifying oil base (bio-wash-oil) for the treatment of psoriasis of the scalp. Skin Pharmacol Physiol. 2004;17:91-97.
18. Carey W, Glazer S, Gottlieb AB, et al. Relapse, rebound, and psoriasis adverse events: an advisory group report. J Am Acad Dermatol. 2006;54(suppl 1):S171-S181.
19. Van de Kerkhof PC, Kragballe K. Recommendations for the topical treatment of psoriasis. J Eur Acad Dermatol Venereol. 2005;19:495-499.
20. Richards HL, Fortune DG, Griffiths CE. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006;20:370-379.
21. Tan J, Thomas R, Wang B, et al. for the CalePso Study Team. Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis. Cutis. 2009;83:157-164.